Core Scientific (CORZ) Amortization of Deferred Charges (2021 - 2025)

Core Scientific has disclosed Amortization of Deferred Charges across 5 years of filings, most recently posting $1.3 million for Q4 2025.

• In Q4 2025, Amortization of Deferred Charges fell 5.45% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $5.7 million (up 50.83% YoY), while the FY2025 annual figure was $6.0 million, up 59.58% from the prior year.
• Amortization of Deferred Charges came in at $1.3 million for Q4 2025 at Core Scientific, up from $1.3 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $5.1 million in Q3 2021 to a low of $199000.0 in Q2 2021.
• Average Amortization of Deferred Charges over 5 years is $1.4 million, with a median of $1.2 million recorded in 2024.
• The largest YoY upside for Amortization of Deferred Charges was 1353.77% in 2022 against a maximum downside of 55.7% in 2022.
• Over 5 years, Amortization of Deferred Charges stood at $350000.0 in 2021, then jumped by 175.14% to $963000.0 in 2022, then retreated by 21.91% to $752000.0 in 2023, then soared by 85.37% to $1.4 million in 2024, then slipped by 5.45% to $1.3 million in 2025.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.